EMCDDA Document Library

Displaying 1 - 10 of 13

no image available

EMCDDA Cannabis Supply reduction meeting. Lisbon, 29th November 2004 — meeting minutes

These are the proceedings of an experts meeting on Cannabis Supply reduction was convened by the EMCDDA at its headquarters in Lisbon. The main purpose of this expert meeting was to contribute to the preparation drafting work of the EMCDDA monograph on cannabis.

Formal Opinion on the draft 2005 work programme of the EMCDDA 22nd Scientific Committee meeting

Formal Opinion on the draft 2005 work programme of the EMCDDA 22nd Scientific Committee meeting

no image available

EU Drugs Strategy (2005-2012)

At its December 2004 meeting, the European Council adopted the EU drugs strategy 2005–12 (the subject of this page), covering an 8-year period. Two consecutive 4-year action plans were subsequently adopted: the EU drugs action plan 2005–08 and the EU drugs action plan 2009–12. The EU drugs...

document cover

2004 study: the role of police stations in the referral of drug using offenders to drug services

Please note: this document forms part of the EMCDDA's institutional record. The information contained within this document may no longer be correct or relevant. More up-to-date information on this topic is available elsewhere on the EMCDDA website. Because of this. caution is recommended before...

document cover

Council Framework Decision 2004/757/JHA of 25 october 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking

This Council Framework Decision lays down down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

no image available

Communication from the Commission to the Council and the European Parliament on the results of the final evaluation of the EU Drugs Strategy and Action Plan On Drugs (2000-2004)

The EU action plan on drugs 2000–04 called upon the European Commission to undertake a mid-term evaluation in 2002 along with a final evaluation in 2004 (the subject of this page).This was the first time that such an evaluation exercise had been undertaken in the drugs field at EU level.

document cover

Public expenditure on drugs in the European Union 2000–2004

This report summarises the available data and figures on expenditure in the field of drugs in the EU and Norway. While some studies in the peer-reviewed literature were found (Finland, France, Spain and the UK) and extensive reports exist for Austria, Belgium, France and the UK, further, data had...

document thumbnail

Legislative activity in the period 2000–2004

This thematic paper, contributing to the European Commission's evaluation of the EU Action Plan 2000-2004, looks at the extent to which legislative attention was paid in the period to actions considered by Member States to be of high priority at the outset of the strategy and action plan. Over 250...

document thumbnail

Drug-using offenders in the European Union 2000–2004

Drug use is directly or indirectly prohibited in all EU countries – except for in medical or scientific circumstances – and punishment for offences varies from administrative to penal, depending on the country. This thematic paper for the Commission's evaluation of the EU Action Plan analyses...

document thumbnail

Legal responses to new synthetic drugs 2000–2004

Written to contribute to the European Commission's Communication on evaluation of the EU Action Plan, this paper highlights evidence of legislative activity related to new synthetic drugs as an indicator of Member States’ commitment to the issue. It also examines to what extent legal activity may...

.